Consistently, we confirmed that treatment with PD-L1 antibodies significantly increased the survival rate of mice with sepsis, suggesting that blocking the PD-1/PD-L1 pathway exerts a protective effect in mice with sepsis. This evidence concerns the gene CD274 and Sepsis.